Drug maker Merck & Co. Inc. has won a Chancery Court case to keep rival SmithKline Beecham Pharmaceuticals Co. from selling a chicken pox vaccine in the United States and Canada for three years.
It’s just hard to know why.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]